Stocks
Vaxcyte, Inc.PCVX
NASDAQHealthcareBiotechnology$54.58-2.90%
A clinical-stage biotechnology company developing conjugate vaccines aimed at preventing serious bacterial infections. Its pipeline is focused on next‑generation pneumococcal vaccines designed to provide broader strain coverage than existing products, with multiple candidates in clinical development...
Market Cap: $7.9B52W Range: $27.66 – $76.61
Congressional Interest in Vaxcyte, Inc. (PCVX)
3 members of Congress have disclosed 6 trades in Vaxcyte, Inc. (PCVX), a Healthcare company. The buy/sell breakdown shows 4 purchases versus 2 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
6
Unique Politicians
3
Buys
4
Sells
2
Who in Congress Is Trading PCVX?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-04-28 | Gilbert Cisneros | buy | $1K – $15K |
| 2025-04-15 | Gilbert Cisneros | buy | $1K – $15K |